Paychex (PAYX) PT Lowered to $125 at Morgan Stanley

Morgan Stanley analyst James Faucette lowered the price target on Paychex (NASDAQ: PAYX) to $125.00 (from $127.00) while maintaining a Equalweight rating.

The analyst comments "While expected ERTC drag is driving near-term estimate reductions, constructive macro commentary, particularly on SMB closure rates, drove intra-day share price recovery. Execution against the contemplated FY25 ex. ERTC acceleration with slighter lower price realization remains key. Lower PT to $125."

You May Also Be Interested In

• Canaan Inc. (CAN) PT Lowered to $2 at BTIG
• Tarsus Pharmaceuticals (TARS) PT Raised to $105 at Jefferies
• BMO Capital Starts Dick's Sporting Goods (DKS) at Underperform